[CLDX] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -7.03%
YoY- -30.39%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 156 967 174 685 2,728 1,425 4,068 -41.90%
PBT -32,808 -29,361 -23,050 -16,538 -12,625 -17,239 -118,897 -19.29%
Tax 732 -6,946 -1,486 764 -16 5,234 -765 -
NP -32,808 -22,415 -21,564 -16,538 -12,625 -17,239 -118,132 -19.21%
Tax Rate - - - - - - - -
Total Cost 32,964 23,382 21,738 17,223 15,353 18,664 122,200 -19.60%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -21,030.77 -2,317.99 -12,393.10 -2,414.31 -462.79 -1,209.75 -2,903.93 39.05%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.56 -0.47 -0.46 -0.42 -0.73 -1.40 -12.61 -40.46%
EPS Diluted -0.56 -0.47 -0.46 -0.42 -0.73 -1.40 -12.61 -40.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.